ArticleMedicine2026
Polypharmacy, pain-related disability, and treatment fragmentation among U.S. adults without clinician advice to limit alcohol or tobacco use: A cross-sectional analysis of the 2022 Medical Expenditure Panel Survey.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Frailty and Incident Low Back Pain in Middle-Aged and Older Adults: Longitudinal Evidence and Genetic Triangulation.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pain-related disability often co-occurs with complex care patterns and high medication burden. Fragmented ambulatory care and polypharmacy may heighten adverse outcomes even among adults without clinician-identified alcohol or tobacco concerns. Using a cross-sectional analysis of the 2022 Medical Expenditure Panel Survey, we estimated the prevalence of ambulatory treatment fragmentation and polypharmacy among US adults with moderate-to-severe pain who had not received clinician advice to limit alcohol or tobacco use, and assessed their associations with emergency and inpatient utilization. The analytic sample included 1547 adults reporting moderate-to-severe pain interference with work. Treatment fragmentation was defined as seeing ≥5 unique provider specialties, and polypharmacy as filling ≥5 unique prescription medications in 2022. Outcomes were the number of emergency department (ED) visits and inpatient discharges. Survey-weighted ordinal logistic regression was used to estimate adjusted associations. High treatment fragmentation and polypharmacy occurred in 27.7% and 61.5% of adults with pain, respectively. The most common specialties were general practice (39.5%) and nursing (35.8%), and the most filled medications were atorvastatin (23.9%), metoprolol (15.5%), and gabapentin (15.4%). Each additional 5 specialties seen was associated with more ED visits (adjusted odds ratio [aOR] = 1.59; 95% confidence interval [CI], 1.15-2.21) but was not significantly associated with inpatient discharges (aOR = 1.38; 95% CI, 0.92-2.05). Each additional 5 unique medications filled was associated with more ED visits (aOR = 1.47; 95% CI, 1.24-1.74) and inpatient discharges (aOR = 1.44; 95% CI, 1.19-1.74). These findings suggest that care fragmentation and polypharmacy are common among adults with pain who have not received clinician advice to limit alcohol or tobacco use and are independently associated with greater acute-care utilization. Strengthening care coordination and medication oversight may help mitigate these risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.